https://www.selleckchem.com/products/PP242.html
To evaluate the efficacy and safety of nebulized magnesium sulphate as a bronchodilator in young children aged 1-24 mo with moderate to severe bronchiolitis in comparison to standard therapy. This was an open labeled randomized controlled trial comprising 60 children with moderate to severe bronchiolitis which was randomly assigned to 2 groups. Intervention group received nebulization with 3mL of 3.2% magnesium sulphate (MgSO ) (iso-osmolar) every 4hourly for 24h in addition to standard care and the control group received standard care al
Like
Comment
Share
